Evidence map›Paper›PMID 40879263›Full record

ArticleInternational journal of cancer2025

Longitudinal patterns of penile human papillomavirus detection among Ugandan men: A prospective sampling study.

Xinyi Feng, Eshan U Patel, Godfrey Kigozi, Patti E Gravitt, Ronald M Galiwango, Molly R Petersen, Fred Nalugoda, Andrew D Redd, Steven J Reynolds, Thomas C Quinn and 2 more

Abstract read
In one paragraph

Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xinyi FengDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Eshan U PatelDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Godfrey KigoziRakai Health Sciences Program, Kalisizo, Uganda.
Patti E GravittConsultant, Baltimore, Maryland, USA.
Ronald M GaliwangoRakai Health Sciences Program, Kalisizo, Uganda.
Molly R PetersenDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Fred NalugodaRakai Health Sciences Program, Kalisizo, Uganda.
Andrew D ReddDivision of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Steven J ReynoldsRakai Health Sciences Program, Kalisizo, Uganda.
Thomas C QuinnDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
M Kate GrabowskiDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Aaron A R TobianDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-0517-3766

Funding

T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartmentsR01DK131926 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Melissa Laird Smith, AARON A TOBIAN · 2022 to 2026
$3.6M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIHNIDDK NIH HHS R01 DK131926NIDDK NIH HHS R01DK131926
6 · The paper itself

Abstract

Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection, yet data on HPV dynamics in African male populations remain limited. We conducted a prospective study of 300 human immunodeficiency virus-negative, sexually active Ugandan men enrolled at circumcision and followed every 6 weeks for 6 months. Penile swabs were collected by clinical staff, and HPV DNA was detected using the Roche polymerase chain reaction-based linear array assay at six time points. We estimated both point and cumulative prevalence of any and high-risk HPV, and assessed empirical and bootstrapped absolute and relative differences to quantify bias from relying solely on baseline testing. The baseline prevalence of any HPV was 49.7%, increasing to 66.0% when cumulative results were considered. Among 27 men with swabs with amplifiable viral or cellular DNA at all six visits, 100% tested positive at least once. HPV detection was often transient: only 6.1% of men with any HPV were consistently positive at all visits. Men who were ever HPV positive reported a younger age at first sex and more sexual partners. Single-timepoint testing significantly underestimated HPV prevalence, with relative biases of 24.7% for any HPV and 40.3% for high-risk HPV. Bootstrap analyses showed that reducing absolute bias to below 5% required two visits for any HPV and three for high-risk HPV, whereas achieving relative bias below 5% required three and five visits, respectively. The results remained consistent in sensitivity analyses that excluded pre-circumcision visits. These findings highlight the limitations of cross-sectional HPV testing and emphasize the importance of repeated sampling for accurate surveillance and vaccine impact assessments in male populations.

Indexed as

PapillomaviridaePapillomavirus InfectionsPenisAdolescentAdultCircumcision, MaleDNA, ViralHuman Papillomavirus VirusesHumansLongitudinal StudiesMaleMiddle AgedPrevalenceProspective StudiesUgandaYoung AdultDNA, ViralHPV prevalencehuman papillomavirus (HPV)longitudinal studypenile infectionUgandan men

Identifiers

PMID40879263
PMCPMC12541568

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.